Skip to main content
. 2019 Feb 14;110(3):903–912. doi: 10.1111/cas.13944

Figure 3.

Figure 3

Peripheral blood analysis of intraperitoneal‐dissemination and liver‐metastasis pancreatic ductal adenocarcinoma (PDAC) mice treated with gemcitabine (GEM). Intraperitoneal‐dissemination and liver‐metastasis PDAC mice were treated with a single dose of GEM 2 d prior to the retrieval of peripheral blood cells and FACS analysis. Mice in the no‐treatment group were injected with PBS alone. A, Wild‐type C57BL/6J mice without tumors. B, Intraperitoneal‐dissemination PDAC mice with or without GEM treatment. C, Liver‐metastasis PDAC mice with or without GEM treatment. Representative FACS scatterplots are shown